Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Race Oncology Ltd. ( (AU:RAC) ) has shared an announcement.
Race Oncology Ltd has released its Corporate Governance Statement, emphasizing its commitment to high standards of accountability and transparency. The company has adopted the ASX Corporate Governance Council’s principles, with adjustments to fit its specific circumstances, aiming to ensure effective management and oversight. This announcement underscores Race Oncology’s dedication to robust governance practices, which are fundamental to its growth and beneficial for its shareholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of cancer therapies. The company is committed to maintaining high standards of accountability and transparency in its operations.
Average Trading Volume: 93,282
Technical Sentiment Signal: Sell
Current Market Cap: A$205M
See more data about RAC stock on TipRanks’ Stock Analysis page.